Position in EDIT
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$46,023
+$3,396 QoQ
Shares Held
18,633
-10.4% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in EDIT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ProShare Advisors LLC holds $466,686,133 across 164 Biotechnology names. EDIT ranks #150 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
373,532 | $166,796,979 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
152,397 | $117,748,018 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
174,013 | $57,575,681 | |
| 4 | INSM |
INSMED Inc
|
283,141 | $46,299,216 | |
| 5 | INCY |
Incyte Corp
|
49,678 | $4,675,693 | |
| 6 | MRNA |
Moderna, Inc.
|
71,342 | $3,624,173 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
31,677 | $2,352,334 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
31,498 | $1,974,924 |
All Filings in EDIT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $46,023 | 18,633 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $42,627 | 20,794 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $61,186 | 17,633 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $44,950 | 20,432 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $25,132 | 21,666 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $34,610 | 27,252 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $70,020 | 20,534 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $75,163 | 16,095 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $152,221 | 20,515 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $190,788 | 18,834 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $124,979 | 16,023 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $111,261 | 13,519 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $93,619 | 12,913 | Shares | Sole | 2023-05-26 | |
| 2022-12-31 | $129,297 | 14,577 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $163,979 | 13,397 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $155,043 | 13,106 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $378,745 | 19,913 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $652,466 | 24,575 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $959,094 | 23,347 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,695,235 | 29,930 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,140,300 | 27,150 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,650,179 | 23,537 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $497,587 | 17,733 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $482,923 | 16,326 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $200,005 | 10,086 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||